Clinical study of Mifepristone and TCM retention enema in treatment of recurrent endometriosis
article
OA: closed
CC0
AI-generated summary
Mifepristone and TCM retention enema improved recurrent endometriosis symptoms more effectively than Gestrinone with fewer side effects and preserved ovulation function.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective: To investigate the new method in the treatment of recurrent endometriosis by integration of traditional Chinese and Weatern medicine.Methods: The patients with recurrent endometriosis were used the Mifepristone,1 time/d,each 12.5 mg,while Mifepristone and TCM retention enema,once 12 weeks,Gestrinone 2.5 mg/time,2 times/1 week,for 12 weeks,as the controls.The clinical efficacy,side-effects and the impact on blood E2 were compared in two groups.Results: Mifepristone and TCM retention enema and Gestrinone in treatment of recurrent endometriosis could improve clinical symptoms,had the better former effect and maintain the serum E2 levels in the follicular phase.Conclusion: Mifepristone and TCM retention enema in treatment of recurrent endometriosis,the effect is better than the Gestrinone,less side-effects,safe,and the patients are easy to accept and without symptoms of estrogen deficiency,stop quick recovery of function after treatment of ovulation,menstruation complex wave short time and is conducive to an early pregnancy.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK